Connor, Clark & Lunn Investment Management (CC&L)’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBH
Connor, Clark & Lunn Investment Management (CC&L)'s ZBH Position: Q4 2025 in Review
Connor, Clark & Lunn Investment Management (CC&L) sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 98,306 shares — an estimated $9.68M sold.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ZBH in Q4 2014 and held it in 13 quarters. The position peaked at $9.68M in Q3 2025. 947 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.
- Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
- Connor, Clark & Lunn Investment Management (CC&L) sold 98,306 Zimmer Biomet shares in Q4 2025, an estimated $9.68M.
- Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Zimmer Biomet in Q4 2014 and held it in 13 quarters.
- Connor, Clark & Lunn Investment Management (CC&L)'s Zimmer Biomet position peaked at $9.68M in Q3 2025.
- 947 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.
Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2025, filed 10 Feb 2026.